Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

注射用达卡巴嗪 - NMPA Drug Approval Details

Approvals/NMPA/Dacarbazine for Injection

Approved

化学药品

Dacarbazine for Injection

国药一心制药有限公司🇨🇳 National Medical Products Administration

Approval Date: Apr 28, 2021
Approval ID: 7LeaeAC97yU
Company: 国药一心制药有限公司
Type: 化学药品

Approval Details

Approval Id: 7LeaeAC97yU
Approval Number: 国药准字H20063419
Generic Name: 注射用达卡巴嗪
Generic Name En: Dacarbazine for Injection
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 400mg
Reg Date: 2021-04-28
Company Name: 国药一心制药有限公司
Company Address: 长春双阳经济开发区怡心路111号
Company Detail Path: /organization/guo-yao-xin-zhi-yao-you-xian-gong-si

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Apr 28, 2021

Approval ID

7LeaeAC97yU

Type

化学药品

Back to NMPA Approvals